-
Editor's Letter
A 50-Year MilestoneEfforts to curb smoking have come a long way, but more work needs to be done.
by Kevin McLaughlin
-
Forward Look
Bane or Boon for Smokers’ Health?FDA weighs regulations for burgeoning e-cigarette market.
by Sharon Reynolds
-
Health Care Reform: What Does It Mean for You?The complex and controversial Affordable Care Act includes reforms that could benefit cancer patients and survivors.
by Bara Vaida
-
Q&A
Pushing Fear AsideLisa Niemi Swayze advocates for research after losing her husband, actor Patrick Swayze, to pancreatic cancer.
by Marci A. Landsmann
-
Get Involved
Sending Get Well WishesJoan A. Smith organizes volunteers' efforts to send cards to cancer patients.
by Maria Wolf
-
Editor's Letter
Cancer Research: Worth Paying ForKevin McLaughlin discusses how one survivor's faith in science underscores the importance of continued funding for cancer research.
by Kevin McLaughlin
-
Forward Look
Truth in AdvertisingSeveral countries explore legality of requiring cigarettes to carry graphic pictures and health warnings.
by Sue Rochman
-
Forward Look
Coming Up ShortA limited supply of cancer medications is affecting care.
by Steve McIver
-
Survivor Profile
Betting on ScienceDiagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.
by Betty Russell
-
More Than a SignatureThe informed consent process is designed to ensure that patients understand risks. But new advances involved in genetic testing and tissue donation may make signing on the dotted line more complex than ever.
by Stephen Ornes
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
